Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R van Lier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|April 1, 1996
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical modelC Renner, S Bauer, U Sahin, et al.
Virology|June 1, 1995
Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectorsK F Copeland, P J Hendrikx, A G Haaksma, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer diseaseN C Bodick, W W Offen, H E Shannon, et al.
Science (New York, N.Y.)|May 6, 1994
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cellsC Renner, W Jung, U Sahin, et al.
Cellular Immunology|July 1, 1994
Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigenM F Romano, R Bisogni, A Lamberti, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Cellular Immunology|May 1, 1993
Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathwayM F Romano, M C Turco, A Stanziola, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|April 1, 1996
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical modelC Renner, S Bauer, U Sahin, et al.
Virology|June 1, 1995
Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectorsK F Copeland, P J Hendrikx, A G Haaksma, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer diseaseN C Bodick, W W Offen, H E Shannon, et al.
Science (New York, N.Y.)|May 6, 1994
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cellsC Renner, W Jung, U Sahin, et al.
Cellular Immunology|July 1, 1994
Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigenM F Romano, R Bisogni, A Lamberti, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Cellular Immunology|May 1, 1993
Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathwayM F Romano, M C Turco, A Stanziola, et al.
Pageof 2